Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement?

Nootropics are drugs used to either treat or benefit cognition deficits. Among this class, methylphenidate is a popular agent, which acts through indirect dopaminergic and noradrenergic agonism and, therefore, is proposed to enhance performance in catecholamine-dependent cognitive domains such as at...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	CNS drugs 2020-10, Vol.34 (10), p.1045-1062
1. Verfasser:	Kapur, Ajay
Format:	Artikel
Sprache:	eng
Schlagworte:	Attention deficit hyperactivity disorder Catecholamines Cognition & reasoning Cognitive ability Cognitive enhancement Demography Dopamine Dopamine receptors Drug dosages Epidemiology Hyperactivity Medicine Medicine & Public Health Memory Mental disorders Methylphenidate Movement disorders Neurodegenerative diseases Neurology Neurosciences Norepinephrine Older people Parkinson's disease Pharmacotherapy Prefrontal cortex Psychiatry Psychopharmacology Quality of life Review Article Schizophrenia Stimulants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!